Kyivstar’s $160 Million Acquisition of Tabletki.ua Signals Major Digital Healthcare Ambitions in Ukraine

Kyivstar Broadens Healthcare Reach with Tabletki.ua—14 Million Reservations Monthly, 14,000+ Pharmacy Partners

Kyivstar—the digital operator listed on Nasdaq and widely known as Ukraine’s connectivity giant—has just expanded its digital healthcare portfolio in a big way. This morning, the company completed its acquisition of 100% of Tabletki.ua for $160 million (payable in local currency). Tabletki.ua is among the country’s most trusted platforms for finding and reserving medicines at pharmacies, and now becomes a key piece of Kyivstar’s digital services strategy.

Tabletki.ua stands out with its scale: it serves millions of users every month, partners with over 14,000 pharmacies across Ukraine, and facilitated an average of 14 million reservations per month in 2025 alone. For the last twelve months ending September 30, 2025, bookings on the platform reached a gross merchandise value (GMV) of UAH 57.3 billion (about $1.19 billion). That momentum shows just how central digital platforms are becoming to healthcare access in Ukraine.

Financial Metrics Underscore Value: 8x Earnings Multiple on $24 Million EBITDA

The agreed price represents a multiple of 8.0x last twelve months’ net earnings. The deal, funded in Ukrainian hryvna, will see Tabletki.ua join forces with an increasingly diversified Kyivstar, which previously acquired digital healthcare platform Helsi (2022) and also owns services like ride-hailing app Uklon and Kyivstar TV.

Accelerating Ukraine’s Digital Health Ecosystem with an “Everyday Essential” Platform

Tabletki.ua’s core strength is its role as a daily utility for Ukrainian households. By letting users search, compare, and reserve medicines in real time from a vast network of pharmacies, the platform brings unprecedented transparency and convenience to the healthcare sector. The company registered a GMV of $1.06 billion in 2024 and continued to grow into 2025—a sign that even during turbulent times, digital-first approaches are winning user trust and adoption.

This acquisition isn’t just about scale. Integrating Tabletki.ua into Kyivstar’s digital ecosystem means healthcare, mobility, entertainment, and connectivity will increasingly converge under one roof. Kyivstar’s president, Oleksander Komarov, underscored the move’s broader ambition: “By combining Kyivstar’s experience in building digital platforms with Tabletki.ua’s strong market position, we will make healthcare services even more accessible and convenient across Ukraine.”

Strategic Perspective: Kyivstar and VEON Signal $1 Billion Ukraine Investment Plan

Kyivstar’s parent, VEON (also traded on Nasdaq), serves 150 million connectivity customers worldwide and is ramping up investment in Ukraine. Together, Kyivstar and VEON have committed $1 billion between 2023 and 2027 for infrastructure, tech, and social ventures—including acquisitions like Tabletki.ua.

Financial leadership at Kyivstar notes that Tabletki.ua’s unaudited management accounts show solid profitability despite market challenges. With prior acquisition Helsi (2022) already building digital health momentum, Kyivstar is gearing up for a much larger ecosystem integration play. In the context of Ukraine’s ongoing need for resilient, accessible, and digital-first solutions, this deal stands out for its scale and vision—and could set the stage for further tech-enabled transformation in the coming years.

Bottom Line: A Major Step Toward Seamless Digital Healthcare Access in Ukraine

Kyivstar’s $160 million acquisition of Tabletki.ua marks the next evolution of Ukraine’s digital healthcare market. With millions of users already relying on Tabletki.ua every month and the platform facilitating well over a billion dollars’ worth of product reservations annually, Kyivstar’s integrated service portfolio could further connect Ukrainians to vital everyday services—right from their smartphones. It’s a signal that digital-first healthcare, nation-spanning connectivity, and investor capital are converging to shape the market’s future.

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI